Expression of concern
Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
Paper Information
Record ID:
44148
Author(s):
Publication Date:
October 20, 2015
Retraction Date:
January 11, 2023
(2.9 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
- Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan
- Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
- Center for Clinical Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
- Kumamoto Saishunso National Hospital, Koshi, Japan
- Kumamoto Ezuko Ryoiku Iryo Center, Kumamoto, Japan
Country:
🇯🇵 JapanArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1371/journal.pone.0279487Citations (34)
34
Total Citations3
Post-Retraction(8.8%)
30
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
723
Days since retraction (latest)
Investigating the Relationship Between Anti-seizure Medications and Bleeding Disorders: A Comprehensive Review of the Current Literature
Areesha Mansoor, Maryam Shahzad, Eeshal Zulfiqar et al. (8 authors)
Drugs - Real World Outcomes
Open Access
Published: Jan 2025
1 citation
1 citation
723 days after retraction
Factors associated with subtherapeutic levels of valproic acid in hospitalized patients with epilepsy: A retrospective cohort study
Tuanthon Boonlue, Papitchaya Sitsuer, Wasinee Phosri et al. (4 authors)
Medicine
Open Access
Published: Nov 2024
667 days after retraction
Personalized antiseizure medication therapy in critically ill adult patients
Sulaiman Almohaish, Aaron M. Cook, Gretchen M. Brophy et al. (4 authors)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Open Access
Published: Mar 2023
4 citations
4 citations
79 days after retraction
Expression of Concern: Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
Unknown Authors
PLoS ONE
Open Access
Published: Jan 2023
1 citation
1 citation
Same day as retraction
Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: Effect of ABCB1 gene polymorphism
Xianhuan Shen, Xinyi Chen, Jieluan Lu et al. (10 authors)
Frontiers in Pharmacology
Open Access
Published: Nov 2022
11 citations
11 citations
47 days before retraction
Moderate alcohol consumption during pregnancy increases potency of two different drugs (the antifungal fluconazole and the antiepileptic valproate) in inducing craniofacial defects: prediction by the in vitro rat whole embryo culture
Francesca Metruccio, Maria Battistoni, Francesca Di Renzo et al. (5 authors)
Archives of Toxicology
Open Access
Published: Nov 2022
1 citation
1 citation
56 days before retraction
Population Pharmacokinetic Analysis of Valsartan in Healthy Chinese Subjects
Haiyun Yang, Ruomei Gao, Xingfang Ji et al. (5 authors)
Clinical Pharmacology in Drug Development
Open Access
Published: Oct 2022
1 citation
1 citation
77 days before retraction
Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach
Jeffrey A. Mensah, Kristina Johnson, Christopher A. Reilly et al. (6 authors)
Epilepsia
Open Access
Published: Aug 2022
9 citations
9 citations
135 days before retraction
Comparative pharmacokinetics of valproic acid among Pakistani and South Korean patients: A population pharmacokinetic study
Muhammad Usman, Qurrat-ul-Ain Shaukat, Muhammad Imran Khokhar et al. (8 authors)
PLoS ONE
Open Access
Published: Aug 2022
6 citations
6 citations
140 days before retraction
Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach
Jeffrey A. Mensah, Kristina Johnson, Christopher A. Reilly et al. (6 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2022
187 days before retraction
Published population pharmacokinetic models of valproic acid in adult patients: a systematic review and external validation in a Chinese sample of inpatients with bipolar disorder
Yannan Zang, Wei Guo, Fang Dong et al. (6 authors)
Expert Review of Clinical Pharmacology
Published: May 2022
9 citations
9 citations
252 days before retraction
Effect of CYP2C19 polymorphisms on serum valproic level acid in Chinese Han patients with schizophrenia
S. Wang, Jinlong Li, Mingfen Song et al. (8 authors)
Scientific Reports
Open Access
Published: Nov 2021
15 citations
15 citations
407 days before retraction
Developing pharmacokinetics–pharmacodynamics model of valproic acid syrup based on prediction of population pharmacokinetics parameter and seizure frequency in Indonesian pediatric epilepsy outpatients
I Komang Prawira Nata Nugraha, Anita Purnamayanti, I Gusti Ngurah Made Suwarba et al. (4 authors)
Journal of Basic and Clinical Physiology and Pharmacology
Open Access
Published: Jun 2021
565 days before retraction
Precision medicine in women with epilepsy: The challenge, systematic review, and future direction
Yi Li, Sai Zhang, M Snyder et al. (4 authors)
Epilepsy & Behavior
Open Access
Published: Mar 2021
15 citations
15 citations
656 days before retraction
Predictive ability of published population pharmacokinetic models of valproic acid in Thai manic patients
Janthima Methaneethorn, Nattawut Leelakanok
Journal of Clinical Pharmacy and Therapeutics
Open Access
Published: Sep 2020
4 citations
4 citations
835 days before retraction
Impact of gender, albumin, and CYP2C19 polymorphisms on valproic acid in Chinese patients: a population pharmacokinetic model
Jinlin Guo, Yayu Huo, Fang Li et al. (7 authors)
Journal of International Medical Research
Open Access
Published: Aug 2020
19 citations
19 citations
893 days before retraction
2-hexyl-4-pentynoic acid, a potential therapeutic for breast carcinoma by influencing RPA2 hyperphosphorylation-mediated DNA repair
Wenwen Ding, David Lim, Zhendong Wang et al. (7 authors)
DNA repair
Published: Jul 2020
9 citations
9 citations
897 days before retraction
Effect of Genetic Polymorphisms of CYP2C19 on the Steady-state Serum Concentrations of Valproic Acid in Chinese Han Patients With Schizophrenia
Shengdong Wang, Jing Li, Ming-Fen Song et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Jul 2020
1 citation
1 citation
905 days before retraction
S-Adenosine Methionine (SAMe) and Valproic Acid (VPA) as Epigenetic Modulators: Special Emphasis on their Interactions Affecting Nervous Tissue during Pregnancy
Asher Ornoy, Maria Becker, Liza Weinstein‐Fudim et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: May 2020
30 citations
30 citations
961 days before retraction
Estimation of apparent clearance of valproic acid in adult Saudi patients
Saeed Alqahtani, Norah Alandas, Abdullah Alsultan
International Journal of Clinical Pharmacy
Published: Jun 2019
16 citations
16 citations
1301 days before retraction
Determination of DP‐VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC–MS/MS: A clinical pharmacokinetics and excretion study
Yi Li, Huizhong Zhan, Yaxin Fan et al. (8 authors)
Drug Testing and Analysis
Published: Mar 2019
8 citations
8 citations
1412 days before retraction
Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case–control study and meta-analysis
Z Wang, Jie Chen, Hai Liang Chen et al. (6 authors)
Bioscience Reports
Open Access
Published: Nov 2018
18 citations
18 citations
1524 days before retraction
Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors
Shansen Xu, Yanan Chen, Mingming Zhao et al. (6 authors)
European Journal of Pharmaceutical Sciences
Published: Jul 2018
28 citations
28 citations
1652 days before retraction
Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model
Shenghui Mei, Weixing Feng, Leting Zhu et al. (10 authors)
European Journal of Clinical Pharmacology
Published: Apr 2018
29 citations
29 citations
1730 days before retraction
Carnitine Deficiency in Chinese Children with Epilepsy on Valproate Monotherapy
Qiliang Li, Wenqi Song, Hong Jin
Indian Pediatrics
Published: Mar 2018
6 citations
6 citations
1777 days before retraction
A systematic review of population pharmacokinetics of valproic acid
Janthima Methaneethorn
British Journal of Clinical Pharmacology
Open Access
Published: Jan 2018
97 citations
97 citations
1825 days before retraction
The pharmacogenomics of valproic acid
Miaomiao Zhu, Huilan Li, Lihong Shi et al. (6 authors)
Journal of Human Genetics
Published: Sep 2017
97 citations
97 citations
1952 days before retraction
Histone deacetylases (HDACs) as therapeutic target for depressive disorders
Paulina Misztak, Patrycja Pańczyszyn-Trzewik, Magdalena Sowa-Kućma
Pharmacological Reports
Published: Aug 2017
64 citations
64 citations
1978 days before retraction
Valproic acid inhibits TTX-resistant sodium currents in prefrontal cortex pyramidal neurons
Bartłomiej Szulczyk, Ewa Nurowska
Biochemical and Biophysical Research Communications
Published: Jul 2017
18 citations
18 citations
2000 days before retraction
Determinación del nivel de dosis del ácido valproico e influencia de los fármacos inductores y no inductores enzimáticos en pacientes voluntarios de la ciudad de Mérida, Venezuela
Juan C. Cotuá, Alexis Morales Ortiz, Maryori Delgado Nilo et al. (7 authors)
Horizonte Médico (Lima)
Open Access
Published: Jun 2017
4 citations
4 citations
2021 days before retraction
Individualized Dosing Algorithms and Therapeutic Monitoring for Antiepileptic Drugs
Sven C. van Dijkman, Sebastian G. Wicha, Meindert Danhof et al. (4 authors)
Clinical Pharmacology & Therapeutics
Open Access
Published: Jun 2017
22 citations
22 citations
2024 days before retraction
Biomarkers in epilepsy–A modelling perspective
Sven C. van Dijkman, Rob A. Voskuyl, Elizabeth C. M. de Lange
European Journal of Pharmaceutical Sciences
Open Access
Published: May 2017
8 citations
8 citations
2065 days before retraction
Additive Interaction of Cisplatin and Histone Deacetylase Inhibitors Combined Treatment in Rhabdomyosarcoma Cells – Αn Isobolographic Analysis
Agata Jarząb, Jarogniew J. Łuszczki, Małgorzata Guz et al. (6 authors)
Anticancer Research
Open Access
Published: Mar 2017
8 citations
8 citations
2126 days before retraction
The ABCC2 c.-24C > T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis
Long Qian, Shu Fang, Yuanliang Yan et al. (6 authors)
Journal of Clinical Neuroscience
Published: Nov 2016
31 citations
31 citations
2261 days before retraction
Quick Stats
Total Citations:
34
Years Since Retraction:
2.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025